Improvement of Adequate Digoxin Dosage: An Application of Machine Learning Approach
Open accessThe DOI matches its Crossref record.
Abstract
Digoxin is a high-alert medication because of its narrow therapeutic range and high drug-to-drug interactions (DDIs). Approximately 50% of digoxin toxicity cases are preventable, which motivated us to improve the treatment outcomes of digoxin. The objective of this study is to apply machine learning techniques to predict the appropriateness of initial digoxin dosage. A total of 307 inpatients who had their conditions treated with digoxin between 2004 and 2013 at a medical center in Taiwan were collected in the study. Ten independent variables, including demographic information, laboratory data, and whether the patients had CHF were also noted. A patient with serum digoxin concentration being controlled at 0.5–0.9 ng/mL after his/her initial digoxin dosage was defined as having an appropriate use of digoxin; otherwise, a patient was defined as having an inappropriate use of digoxin. Weka 3.7.3, an open source machine learning software, was adopted to develop prediction models. Six machine learning techniques were considered, including decision tree (C4.5), k-nearest neighbors (kNN), classification and regression tree (CART), randomForest (RF), multilayer perceptron (MLP), and logistic regression (LGR). In the non-DDI group, the area under ROC curve (AUC) of RF (0.912) was excellent, followed by that of MLP (0.813), CART (0.791), and C4.5 (0.784); the remaining classifiers performed poorly. For the DDI group, the AUC of RF (0.892) was the best, followed by CART (0.795), MLP (0.777), and C4.5 (0.774); the other classifiers’ performances were less than ideal. The decision tree-based approaches and MLP exhibited markedly superior accuracy performance, regardless of DDI status. Although digoxin is a high-alert medication, its initial dose can be accurately determined by using data mining techniques such as decision tree-based and MLP approaches. Developing a dosage decision support system may serve as a supplementary tool for clinicians and also increase drug safety in clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473
“Moreover, Hu et al. [128] performed ML analysis with techniques like classification and regression trees, multilayer perceptron network, k-nearest neighbor to find out the safe initial dose of cardiac drug digoxin.”
MethodRole of artificial intelligence in patient safety outcomes: systematic literature review
Choudhury, A., & Asan, O. (2020) · JMIR Medical Informatics · doi:10.2196/18599 · Cited by 440
Machine Learning in Pharmacometrics: Opportunities and Challenges
McComb, M., Bies, R., & Ramanathan, M. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14801 · Cited by 128
“9 ng/mL were classified as inappropriate and used as the response variable.(94) The predictive performance was assessed using the ROC AUC.”
MethodHow will machine learning inform the clinical care of atrial fibrillation?
Siontis, K. C., Yao, X., Pirruccello, J. P., Philippakis, A. A., & Noseworthy, P. A. (2020) · Circulation Research · doi:10.1161/circresaha.120.316401 · Cited by 61
Metadata
- Authors
- Hu, Y.-H., Tai, C.-T., Tsai, C.-F., & Huang, M.-W.
- Venue
- Journal of Healthcare Engineering
- Publisher
- Wiley
- Published
- 2018-08-19
- Volume
- 2018
- Pages
- 1-9
- ISSN
- 2040-2295 (ISSN-L)
- 2040-2309
- OpenAlex
- W2885150510
- Cited by
- 43
- References
- 0
- FWCI
- 7.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Improvement of Adequate Digoxin Dosage: An Application of Machine Learning Approach. https://app.cochat.ai/papers/10.1155/2018/3948245
- The paper
- Hu, Y.-H., Tai, C.-T., Tsai, C.-F., & Huang, M.-W. (2018). Improvement of Adequate Digoxin Dosage: An Application of Machine Learning Approach. Journal of Healthcare Engineering. https://doi.org/10.1155/2018/3948245
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.